Insider filing · TRDA
Entrada Therapeutics, Inc.
TRDA · Healthcare · 31 filings in 24 months
ticker →
Mpm Bioventures 2018, L.P. sold $1.9M of Entrada Therapeutics (TRDA)
Executed Sep 4, disclosed Sep 9, 5 days later.
Value, as filed
$1.9M
259,837 sh across 3 lots
Executed
Sep 4
the trade date, as filed
Disclosed
Sep 9
5 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
MP
Mpm Bioventures 2018, L.P.
10% owner
profile →
Mpm Bioventures 2018, L.P. (10% owner) filed 5 Form 4 reports as a reporting entity in the trailing twelve months (1 purchase, 4 sales), most often in Entrada Therapeutics, Inc. (TRDA). Across 1 priced purchase filing, the average 21-session return was -20.7% from execution and -15.6% from disclosure (delay-adjusted; derived). The largest single filing was $20.0M of AKTS (1,112,777 sh × $18.00, as filed), executed Jan 12.
The name
TRDAHealthcare · Entrada Therapeutics, Inc., is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new c…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Mpm Bioventures 2018, L.P. in TRDA
TRDASALE
Entrada Therapeutics, Inc.
$617K86,482 sh across 3 lots
Exec Sep 1
Filed Sep 3 · 7:21 PM ET TRDASALE Entrada Therapeutics, Inc. $590K
83,181 sh across 2 lots
Exec Aug 27
Filed Aug 31 · 6:26 PM ET TRDASALE Entrada Therapeutics, Inc. $462K
62,714 sh across 3 lots
Exec Aug 24
Filed Aug 26 · 9:27 PM ET